Early patient data suggests that FlowOx™ may be able to alleviate Multiple Sclerosis (MS) symptoms
A case series report on 7 patients conducted by Gabriela Fortes (MD), Neurologist, suggests that FlowOx™ has a surprising and profound effect in alleviating MS related spasticity and pain.
An exploratory clinical trial is currently being carried out by Neuro-SysMed, Norway’s leading center of excellence in Neurological research, to confirm the case series findings.


IN THE PRESS
First RCT to show improved walking capacity
First multi-centre randomized controlled trial using FlowOx™, published in Journal of Vascular Surgery, shows improved walking capacity for patients with intermittent claudication, also known as “windows shopper’s disease”.
Read more here!
OUR PARTNERS
ABOUT FLOWOX™
Is FlowOx™ for me?
Without FlowOx™ I would have lost my other leg as well and I am not sure I would have been here today. That is what FlowOx™ has done for me..
Listen to Stine’s and Hans Thomas’ stories
Stine’s own story
First FlowOx™ patient, Hans Thomas

OTIVIO
FlowOx™ by Otivio
Otivio AS is a Norwegian medtech company based in Oslo. FlowOx™ is a non-invasive medical device for home treatment addressing insufficient blood flow to the limbs associated with peripheral arterial disease, diabetes and other arterial blood flow deficiencies. FlowOx™ is documented to reduce or eliminate these outcomes which represent a big impact on Quality of Life and health care costs. FlowOx™ is CE marked (CE2460) and available in various countries.
GET IN TOUCH